Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-01

FDA Approved: CASODEX — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CASODEX (bicalutamide) submitted by ANI Pharmaceuticals, Inc. This action updates the regulatory status of the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Casodex (bicalutamide)

Snippet

SUPPL AP for CASODEX (BICALUTAMIDE)